Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave

Information regarding the efficacy of the recombinant adenovirus type-5-vectored (CanSino Bio) vaccine against the COVID-19 disease in a real-life setting is limited. A retrospective cohort study was carried out in the teaching university community of the metropolitan area of Monterrey, Mexico, thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmán-López, Santos, Darwich-Salazar, Armine, Bocanegra-Ibarias, Paola, Salas-Treviño, Daniel, Flores-Treviño, Samantha, Pérez-Alba, Eduardo, Nuzzolo-Shihadeh, Laura M., Pérez-Rodríguez, Edelmiro, Camacho-Ortiz, Adrián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143224/
https://www.ncbi.nlm.nih.gov/pubmed/35632412
http://dx.doi.org/10.3390/vaccines10050656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143224/
https://www.ncbi.nlm.nih.gov/pubmed/35632412
http://dx.doi.org/10.3390/vaccines10050656

Ejemplares similares